Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI ... or AmpC-type beta-lactamases that confer resistance to third generation cephalosporins.

This Poster will be available on the Company's website on the "Publications: Posters & Presentations” page under the "Our Science” tab. ORLYNVAH™ is a novel oral penem antibiotic for ...

A student presents her research poster to Katia Del Rio Tsonis ... Brown’s research project concentrated on antibiotic resistance. Fernandes added this is a valuable opportunity for first-year ...

The poster presented at ECCMID was ... as experts raise concerns about antibiotic resistance. Iterum provides updates from the FDA's Antimicrobial Drugs Advisory Committee meeting on its NDA ...

A research team led by Professor Tong Zhang from the Department of Civil Engineering of Faculty of Engineering at the ...

One way microplastics fuel antibiotic resistance is by acting as “hotspots” for bacteria to interact and exchange genes.

A study presented at ESCMID Global 2025 reveals that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.

Could a gene regulatory network in gut microbes have evolved its elaborate and tightly regulated molecular machinery only to pump out antibiotics indiscriminately? Researchers show this is an ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...